| scholarly article | Q13442814 |
| P2093 | author name string | Johannes Oldenburg | |
| Aida Inbal | |||
| Manuel Carcao | |||
| Diane Nugent | |||
| Ramin Tehranchi | |||
| Anders Rosholm | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5111-5117 | |
| P577 | publication date | 2012-03-26 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency | |
| P478 | volume | 119 |
| Q38100849 | A child with acquired factor XIII deficiency: case report and literature review |
| Q93181359 | Acquired factor XIII deficiency: A review |
| Q45878371 | Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy; characterization of the antibody |
| Q33435484 | Alternatives to allogeneic platelet transfusion. |
| Q38109321 | Alternatives to blood transfusion |
| Q38038687 | Biology of Factor XIII and clinical manifestations of Factor XIII deficiency |
| Q27026565 | Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency? |
| Q42246877 | Coagulation factor XIIIa is inactivated by plasmin. |
| Q30402137 | Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A2. |
| Q42688987 | Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study |
| Q39218599 | Diagnosis and management of severe congenital factor XIII deficiency in the Emergency Department: lessons from a "model" family |
| Q42182012 | Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency |
| Q36705168 | Factor XIII deficiency presenting with intracerebral bleed. |
| Q26820824 | Future of coagulation factor replacement therapy |
| Q36749484 | Impaired dimer assembly and decreased stability of naturally recurring R260C mutant A subunit for coagulation factor XIII. |
| Q38688608 | Minimal factor XIII activity level to prevent major spontaneous bleeds |
| Q38070913 | New developments in the area of factor XIII. |
| Q36906072 | New developments in the management of congenital Factor XIII deficiency |
| Q36719655 | Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma-derived human FXIII concentrate in animals |
| Q38206850 | Novel products for haemostasis |
| Q38206849 | Novel products for haemostasis - current status |
| Q45872670 | Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency |
| Q48543476 | Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency. |
| Q43496460 | Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients |
| Q49966943 | Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency. |
| Q38743779 | Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results. |
| Q48728275 | Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture. |
| Q45866130 | Severe bleeding diatheses in an elderly patient with combined type autoantibody against factor XIII A subunit; novel approach to the diagnosis and classification of anti-factor XIII antibodies. |
| Q38231336 | The burden and management of FXIII deficiency |
| Q45870960 | The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency--the first experience |
| Q47698980 | Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure |
| Q38787759 | Treatment of rare factor deficiencies in 2016. |
| Q47228028 | Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH. |
| Q45883000 | Women leaders in hematology: Inspirations & insights |
| Q86506699 | [Identification of genetic defects in a Chinese pedigree with factor XIII deficiency: case report and literature review] |
Search more.